ART symposium: comment on sessions

Slides:



Advertisements
Similar presentations
Regulators’ Code July Regulators’ Code A statutory Code Came into effect in April 2014, replacing the Regulators’ Compliance Code All local authorities.
Advertisements

Auditing, Assurance and Governance in Local Government
CFSAN’s Peer Review for Risk Assessments Robert L. Buchanan, Sherri Dennis, and Marianne Miliotis.
Pediatric Ethics Subcommittee of Pediatric Advisory Committee, September 10, 2004 Analysis of Research Protocols Involving Children: Combining Subparts.
Implementing the new Workload Policy Heads of School Workshop April 2010.
Promoting Excellence in Family Medicine Enabling Patients to Access Electronic Health Records Guidance for Health Professionals.
Frequently Asked Questions (FAQ) prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Session 3 - Plenary on implementing Principle 1 on an Explicit Policy on Regulatory Quality, Principle 3 on Regulatory Oversight, and Principle 6 on Reviewing.
VIRGINIA PUBLIC-PRIVATE EDUCATION FACILITIES AND INFRASTRUCURE ACT OF 2002 (PPEA) Augusta County Board of Supervisors Wednesday, January 6, 2009.
National Human Rights Consultation: Getting involved Rachel Ball Human Rights Law Resource Centre Ltd
Tarrytown meeting Regulation of ART in New Zealand What have we got and how did we get there Sylvia Rumball Chair, Advisory Committee on Assisted Reproductive.
UK Wide Core Skills & Training Framework Findings of 2 nd Stage Consultation and Implications for Development of the Framework.
Implementation of EU Electronic Communication Directives.
Environment Protection (Waste to Resources) Policy TIANA NAIRN November 08.
GCP & ETHICS COMMITTEES Ravi Rengachari Vector Control Research Centre PONDICHERRY.
Policy Influencing strategies & Tactics. What is Public policy? Public policy: It is a guideline to the actions of the governments in addressing societal.
UNEP Training Resource Manual Topic 10 Slide 1. UNEP Training Resource Manual Topic 10 Slide 2 EIA is a process to: F gather information necessary for.
Environmental Management System Definitions
Acknowledgement of country
Australian Health Ethics Committee Professor Colin Thomson address to International Dialogue on Ethics European Commission Bureau of European Policy Advisers.
A presentation to the AABHL Conference Auckland 14 July 2012 Dr John Angus PhD and Alison Douglass LLB, MBHL Informed Consent and Assisted Reproductive.
4. Regulatory Measures and Procedures 1. General measures Include regulations or administrative rules of general applicability aimed at implementing or.
Student Council Training Eddie Rowley Students’ Union Liaison & Quality Coordinator.
IPASA presentation to Portfolio Committee on Health 31 October 2014 Abeda Williams.
Overview Strengths of parliamentary committees Overview of reformed committee system Example of previous road safety inquiry Becoming involved.
GENET - European NGO Network on Genetic Engineering: 44 members in 24 countries Mission: to provide information on gene technologies and related topics.
NGO/Associations Law- Benchmarks for a law that meets International Standards/Principles March 2010.
PP 620: Public Policy and Health Administration Unit One Seminar Kris R. Foote, J.D., M.P.A., M.S.W. Kaplan University.
Liberating the NHS: Developing the healthcare workforce Workforce planning, education and training Consultation Engagement.
T Mr.Willy Musinguzi, EAC. .Overview of EAC SQMT Infrastructure How EAC standards are Harmonized and Implemented How EAC Quality Infrastructure relates.
Child Safe Standards How effective is your leadership team in promoting a child safe culture in your organisation? 2 June 2016.
AEMCPresentation to GWCFPAGE 1 AEMC and Rule changes Presentation to AEMO Gas Wholesale Consultative Forum Kamlesh Khelawan Director This presentation.
1 Dr David Coles Ethics and Science European Commission ACTIVITIES on ETHICS in The Science and Society Programme.
CAPACITY BUILDING PROGRAMME ON BOARD INDUCTION AND EVALUATION
Developments of Bioethics in Europe and Lithuania
Financial Services Laws General Amendment Bill
BLM Decision Making Process
Research on Pre-implantation Embryos: Ethical Imperatives
Principles of Good Governance
EU Law Law 326.
Session 3 General RIA Training 6–8 July 2009 EuropeAid/125317/D/SER/TR
The Citizen in the centre in EU, Bratislava November,2005
Public Participation in Biofuels Voluntary
European Union Institutions Law Making
Overview of public participation in strategic decision-making in the UNECE area David Aspinwall.
On Human Gene Editing: International Summit Statement
Portfolio Committee on Public Works
The EAC Quality Infrastructure and WTO TBT Agreement.
Money Bills Amendment Procedure and Related Matters Bill [B 75–2008]
Parliamentary and European Law Making Institutions of the European Union Notes:
Presentation on the Joint Standing Committee on Financial Management of Parliament 07 September 2016.
Data workshop WhOSE DATA IS IT ANYWAY? Alexia Christie
Financial Management of Parliament Bill
Setting Actuarial Standards
General Data Protection Regulation
Statistics Governance and Quality Assurance: the Experience of FAO
Chapter 10Ethical Issues in Health Care
Data Access and Stewardship
Disability Rights and the United Nations: Developing Hard Law
Identifying Basic Principles for Moving Forward
Quality Risk Management ICH Q9 Frequently Asked Questions (FAQ)
Informed Consent (SBER)
Moral Decision-Making
International Training Centre of the ILO
Ethical and Policy Issues in Human Germ line Modifications
OHSC 2018 CONSULTATIVE WORKSHOP - GAUTENG PROVINCE ENFORCEMENT
Law-making through parliament
CCWG Accountability Recommendations
democracy DELIBERATIVE DEMOCRACY Matt Bennett
IESBA CAG Meeting New York, USA March 4, 2019
Presentation transcript:

ART symposium: comment on sessions Gareth (specific issue of embryo research), Colin –’elusive search for consensus’ theoretical analysis of strategies/solutions to regulating (not all great) - formulating policy – background morally diverse views. Short amount of time – focus on one particular theme in particular … emerged from Gareth and Colins presentations … ‘road blocks’/regulatory impasse under the HART Act – the implications it has on the ‘legitimacy’ of policy (is it consistent with accepted values/principles underpinning legal system). Jeanne Snelling (Phd) Bioethics Centre / Faculty of law University of otago

Overview Gareth: embryos under the law: inconsistency, Embryo research ‘restrictive by default’: ACART ‘advice’ 2007 Is the HART Act ‘fit for purpose’? Colin: regulatory challenges: ‘normative’ challenge: the ‘ought’ question HART Act 2004 … ? ‘robust and flexible’ framework? guiding principles Preimplantation HLA tissue typing: Procedural legitimacy: process 2009-2014; Substantive legitimacy: regulatory position justified according to accepted principles? Gareth: roadblock – advice not adopted in 2007 – outcome is inconsistency, bad outcome for patients, (stem cells - science & society) Colin: unilateratal executive decision making: ‘executive fiat’ - doubts as to whether power vested in Minister. Purpose of the Act: Secure the benefits of ART/research for individuals and society – by taking appropriate measures for the protection and promotion of the health, safety, dignity, and rights of all individuals, but particularly those of women and children, in the use of these procedures and research. Provide a robust and flexible framework for regulating and guiding the performance of ART and Research Principles to guide …

The ‘problem’ … ? While lots of ACART’s advice/policy revision has progressed - not true if all … revisit the Framework that we have Embryo Research: advice to Minister, extensive consultation (2007-asked not to undertake further work) ) Tissue typing – guidelines/advice with Minister from 2010 – 2014 Suggest - HART Act establishes broad, mid-level principles and empowers a quasi-independent body to formulate guidelines and provide advice to the Minister with what prima facie appears to be minimal political involvement.

Who decides … ? 35. Functions of ACART 36. ACART may issue guidelines only after 37. & 38. ACART to provide specific advice 1a. Providing a reasonable opportunity for public submissions … 2. When ACART issues guidelines … it must a. give copies to Minister, D- G of health, ECART and providers … 3. Minister must present copy of guidelines to HoR as soon as practicable after receiving To issue guidelines & give advice to ECART … keep under review Provide advice to the Minister on aspects/issues of assisted reproductive procedures & research Requirement to consult (s 41) Before ACART issues guidelines to ECART, it must consult on the proposed guidelines with the Minister ACART must, within timeframes agreed with the Minister, provide Minister with information, advice and if it thinks fit, recommendations on … research ART … including preimplantation selection Before giving ‘significant advice’ to Minister ACART must given interested parties/public a reasonable opportunity to make submissions Procedural: requirements of ACART, Minister – advice/guidelines Some of us who have spent time analysing the HART Act 2004 – suggest that intention of parliament ACART was an independent “policy making body”, versus an alternative interpretation that it is merely an ‘advisory’ committee ? Mechanics: .. The Act only requires that ACART “consult” with the Mr on proposed guidelines and the Mr must merely “table” guidelines in Parliament prior to introducing them. While this the spirit of the law … Is the Minister given power to make unilateral policy decisions, which is effectively what happens if ACART’s advice is rejected without providing a public response . [research on embryos – considered under s 37- HLA tissue typing : ’Consultation with the Minister on the Proposed PGD with HLA TT Guidelines’ ACART – s 34(2) Minister may terminate the appointment of member by written notice.

Procedural legitimacy? Does it matter? HART Act principles Procedural legitimacy? Does it matter? Substantive legitimacy: policy position justifiable? – not adopting advice/guidelines is endorsing a regulatory position (default) Purpose/principles of Act: ‘secure the benefits’: taking appropriate measures to protect & promote health, safety, dignity & rights ‘robust & flexible framework’ Expectation: reasoned & transparent response to advice … application of principles … ongoing dialogue Eg: research (embryo research not permissible); HLA TT (TT only lawful if future child at risk of a genetic d/or, unlawful if no genetic risk). Procedural legitimacy: does the debate matter? Substantive legitimacy: is the policy position legitimate – ie by reference to principles endorsed in a liberal democratic society – HART Act principles, plus the bigger picture of regulatory legitimacy (transparency, proportionality, consistency). Are we achieving this in the hard cases? Transparency & accountability to the public –requires a public response to consultation ... Justification – subject to Act, by ACART, Minister … Need to make the HART Act processes work better – don’t keep stumbling on the big hurdles … on-going challenge … important given trajectory of science… [Purpose: taking appropriate measures for the protection and promotion of the health, safety, dignity, and rights of all individuals, but particularly those of women and children.}

Doorstep … Next Generation Sequencing: Combines power of single gene mutation detection & complete 24-chromosome screening.

ART symposium: comment on sessions Jeanne Snelling (Phd) Bioethics Centre / Faculty of law University of otago